Aberrant histone modifications in peripheral blood mononuclear cells from patients with Henoch-Schönlein purpura

Clinical Immunology

Volumn 146, Issue 3, 2013, Pages 165-175

  Luo, Shuangyan ^a   Liang, Gongping ^a   Zhang, Peng ^a   Zhao, Ming ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cytokines; Henoch Sch nlein purpura; ; Histone modifications; ; PBMCs;

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CXCL4 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYSINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSCRIPTION FACTOR TIM 1; UNCLASSIFIED DRUG;

ACETYLATION; ADOLESCENT; ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE LOCUS; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MALE; METHYLATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIMETHYLATION;

EID: 84872847489     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2012.12.009     Document Type: Article

References (41)

1. Keskin N., Civilibal M., Elevli M., Koldas M., Duru N.S., Ozturk H. Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura. Pediatr. Nephrol. 2011, 26:1989-1993.
2. Faille-Kuyber E.H., Kater L., Kooiker C.J., Dorhout Mees E.J. IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schonlein syndrome. Lancet 1973, 1:892-893.
3. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37:187-192.
4. Yang Y.H., Huang Y.H., Lin Y.L., Wang L.C., Chuang Y.H., Yu H.H., Lin Y.T., Chiang B.L. Circulating IgA from acute stage of childhood Henoch-Schonlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin. Exp. Immunol. 2006, 144:247-253.
5. Uchiyama K., Yoshida N., Mizobuchi M., Higashihara H., Naito Y., Yoshikawa T. Mucosal IgA deposition [correction of depositon] in Henoch-Schonlein purpura with duodenal ulcer. J. Gastroenterol. Hepatol. 2002, 17:728-729.
6. Hisano S., Matsushita M., Fujita T., Iwasaki H. Activation of the lectin complement pathway in Henoch-Schonlein purpura nephritis. Am. J. Kidney Dis. 2005, 45:295-302.
7. Lin Q., Min Y., Li Y., Zhu Y., Song X., Xu Q., Wang L., Cheng J., Feng Q., Li X. Henoch-Schonlein purpura with hypocomplementemia. Pediatr. Nephrol. 2012, 27:801-806.
8. Nielsen H.E. Epidemiology of Schonlein-Henoch purpura. Acta Paediatr. Scand. 1988, 77:125-131.
9. Tancrede-Bohin E., Ochonisky S., Vignon-Pennamen M.D., Flageul B., Morel P., Rybojad M. Schonlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. Arch. Dermatol. 1997, 133:438-442.
10. Zhao S., Long H., Lu Q. Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin. Rev. Allergy Immunol. 2010, 39:3-9.
11. Zhang P., Su Y., Zhao M., Huang W., Lu Q. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris. Eur. J. Dermatol. 2011, 21:552-557.
12. Ngalamika O., Zhang Y., Yin H., Zhao M., Gershwin M.E., Lu Q. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J. Autoimmun. 2012, 39:451-465.
13. Wilson C.B., Rowell E., Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 2009, 9:91-105.
14. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
15. Tian Z., Tolic N., Zhao R., Moore R.J., Hengel S.M., Robinson E.W., Stenoien D.L., Wu S., Smith R.D., Pasa-Tolic L. Enhanced top-down characterization of histone post-translational modifications. Genome Biol. 2012, 13:R86.
16. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
17. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
18. Baguet A., Bix M. Chromatin landscape dynamics of the Il4-Il13 locus during T helper 1 and 2 development. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11410-11415.
19. Tanaka S., Motomura Y., Suzuki Y., Yagi R., Inoue H., Miyatake S., Kubo M. The enhancer HS2 critically regulates GATA-3-mediated Il4 transcription in T(H)2 cells. Nat. Immunol. 2011, 12:77-85.
20. Wang Q., Ren S.H., Dong W., Fang J. Effects of transcription factor T-bet, GATA-3, FoxP3 and CD4(+)CD25(+)regulatory T cells in pathogenesis of child Hench-Schonlein purpura. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012, 20:133-136.
21. Swist K., Pajtasz-Piasecka E. The influence of transcription factors on CD4+ T cell differentiation. Postepy Hig. Med. Dosw. (Online) 2011, 65:414-426.
22. Ansel K.M., Djuretic I., Tanasa B., Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu. Rev. Immunol. 2006, 24:607-656.
23. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P.A., Mantovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998, 187:129-134.
24. Fleischer J., Grage-Griebenow E., Kasper B., Heine H., Ernst M., Brandt E., Flad H.D., Petersen F. Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J. Immunol. 2002, 169:770-777.
25. McIntire J.J., Umetsu S.E., Akbari O., Potter M., Kuchroo V.K., Barsh G.S., Freeman G.J., Umetsu D.T., DeKruyff R.H. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2001, 2:1109-1116.
26. Kobayashi N., Karisola P., Pena-Cruz V., Dorfman D.M., Jinushi M., Umetsu S.E., Butte M.J., Nagumo H., Chernova I., Zhu B., Sharpe A.H., Ito S., Dranoff G., Kaplan G.G., Casasnovas J.M., Umetsu D.T., Dekruyff R.H., Freeman G.J. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007, 27:927-940.
27. Umetsu S.E., Lee W.L., McIntire J.J., Downey L., Sanjanwala B., Akbari O., Berry G.J., Nagumo H., Freeman G.J., Umetsu D.T., DeKruyff R.H. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat. Immunol. 2005, 6:447-454.
28. Van Bruaene N., Perez-Novo C.A., Basinski T.M., Van Zele T., Holtappels G., De Ruyck N., Schmidt-Weber C., Akdis C., Van Cauwenberge P., Bachert C., Gevaert P. T-cell regulation in chronic paranasal sinus disease. J. Allergy Clin. Immunol. 2008, 121:1435-1441. (1441 e1431-1433).
29. Chen G.Y., Osada H., Santamaria-Babi L.F., Kannagi R. Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16894-16899.
30. Lit L.C., Wong C.K., Li E.K., Tam L.S., Lam C.W., Lo Y.M. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 2007, 34:89-96.
31. Zhang Q., Long H., Liao J., Zhao M., Liang G., Wu X., Zhang P., Ding S., Luo S., Lu Q. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J. Autoimmun. 2011, 37:180-189.
32. Nalbant S., Koc B., Top C., Kucukardali Y., Baykal Y., Danaci M., Kocer I.H. Hypersensitivity vasculitis and cytokines. Rheumatol. Int. 2002, 22:244-248.
33. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007, 148:32-46.
34. Furuzawa-Carballeda J., Vargas-Rojas M.I., Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 2007, 6:169-175.
35. Lau K.K., Suzuki H., Novak J., Wyatt R.J. Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr. Nephrol. 2010, 25:19-26.
36. Kawasaki Y. The pathogenesis and treatment of pediatric Henoch-Schonlein purpura nephritis. Clin. Exp. Nephrol. 2011, 15:648-657.
37. Tsuruga K., Watanabe S., Oki E., Aizawa-Yashiro T., Yoshida H., Imaizumi T., Ito E., Tanaka H. Imbalance towards Th1 pathway predominance in purpura nephritis with proteinuria. Pediatr. Nephrol. 2011, 26:2253-2258.
38. Tami C., Silberstein E., Manangeeswaran M., Freeman G.J., Umetsu S.E., DeKruyff R.H., Umetsu D.T., Kaplan G.G. Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions. J. Virol. 2007, 81:3437-3446.
39. Besbas N., Saatci U., Ruacan S., Ozen S., Sungur A., Bakkaloglu A., Elnahas A.M. The role of cytokines in Henoch Schonlein purpura. Scand. J. Rheumatol. 1997, 26:456-460.
40. Rengarajan J., Szabo S.J., Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today 2000, 21:479-483.
41. Romagnani P., Maggi L., Mazzinghi B., Cosmi L., Lasagni L., Liotta F., Lazzeri E., Angeli R., Rotondi M., Fili L., Parronchi P., Serio M., Maggi E., Romagnani S., Annunziato F. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J. Allergy Clin. Immunol. 2005, 116:1372-1379.